Rate My Professor Vijay Suppiah

Dr. Vijay Suppiah is a Senior Lecturer in Pharmacy at the School of Pharmacy and Biomedical Sciences, College of Health, Adelaide University. A pharmacy-trained educator and researcher, he is dedicated to improving how medicines are selected and used to achieve optimal patient outcomes. He holds a PhD from Queen's University Belfast (2003-2006), a BSc (Hons) in Pharmacy from the National University of Singapore (1999-2003), and a Diploma in Health Counselling (2008). As a passionate educator, Dr. Suppiah coordinates courses in pharmacotherapeutics and dosage form design. He supervises undergraduate and postgraduate students, having guided several higher degree by research students to completion as primary supervisor, and is eligible to supervise Masters and PhD candidates. His earlier work in immunogenetics identified genetic markers predicting response to hepatitis C treatment, contributing to the introduction of pharmacogenomic testing into clinical practice in Australia and advancing personalized medicine.

Dr. Suppiah's research centers on precision medicine, pharmacogenomics, clinical pharmacy, psychopharmacology, mental health, and pharmacy practice. He leads multidisciplinary, industry-connected programs addressing pharmacogenomics in multi-morbidity, evidence-based mental health care, psychotropic monitoring, medication safety, adverse drug effects, and pharmacy workforce wellbeing. Key publications include Suppiah et al. (2009) 'IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy' in Nature Genetics; Suppiah et al. (2011) 'IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort' in PLoS Medicine; Read et al. (2017) 'Zinc is a potent and specific inhibitor of IFN-λ3 signalling' in Nature Communications; and Patin et al. (2012) 'Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection' in Gastroenterology. He received the Pharmacy Guild of Australia Scholarship (2022-2024). His projects translate evidence into practical tools, clinical guidelines, and models of care across hospital and community settings, enhancing patient outcomes and professional resilience through widespread collaborations.